nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2A—chronic obstructive pulmonary disease	0.511	1	CbGaD
Pramipexole—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00801	0.415	CbGeAlD
Pramipexole—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00291	0.151	CbGeAlD
Pramipexole—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000866	0.0449	CbGeAlD
Pramipexole—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000741	0.0384	CbGeAlD
Pramipexole—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000737	0.0382	CbGeAlD
Pramipexole—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000593	0.0307	CbGeAlD
Pramipexole—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000533	0.0276	CbGeAlD
Pramipexole—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000506	0.0262	CbGeAlD
Pramipexole—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000489	0.0253	CbGeAlD
Pramipexole—HTR2B—lung—chronic obstructive pulmonary disease	0.000486	0.0252	CbGeAlD
Pramipexole—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000473	0.0245	CbGeAlD
Pramipexole—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.00043	0.0223	CbGeAlD
Pramipexole—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000425	0.022	CbGeAlD
Pramipexole—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000394	0.0204	CbGeAlD
Pramipexole—DRD2—lung—chronic obstructive pulmonary disease	0.000394	0.0204	CbGeAlD
Pramipexole—ADRA2C—lung—chronic obstructive pulmonary disease	0.000383	0.0198	CbGeAlD
Pramipexole—HTR2A—trachea—chronic obstructive pulmonary disease	0.000361	0.0187	CbGeAlD
Pramipexole—ADRA2A—lung—chronic obstructive pulmonary disease	0.000305	0.0158	CbGeAlD
Pramipexole—HTR2A—lung—chronic obstructive pulmonary disease	0.00026	0.0135	CbGeAlD
Pramipexole—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000492	CcSEcCtD
Pramipexole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000178	0.000491	CcSEcCtD
Pramipexole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00049	CcSEcCtD
Pramipexole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00049	CcSEcCtD
Pramipexole—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000489	CcSEcCtD
Pramipexole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000176	0.000486	CcSEcCtD
Pramipexole—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000484	CcSEcCtD
Pramipexole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000483	CcSEcCtD
Pramipexole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000479	CcSEcCtD
Pramipexole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000478	CcSEcCtD
Pramipexole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000478	CcSEcCtD
Pramipexole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000477	CcSEcCtD
Pramipexole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000172	0.000475	CcSEcCtD
Pramipexole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000475	CcSEcCtD
Pramipexole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000473	CcSEcCtD
Pramipexole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000473	CcSEcCtD
Pramipexole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000471	CcSEcCtD
Pramipexole—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00047	CcSEcCtD
Pramipexole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000469	CcSEcCtD
Pramipexole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.000467	CcSEcCtD
Pramipexole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000466	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.000466	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000169	0.000466	CcSEcCtD
Pramipexole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000462	CcSEcCtD
Pramipexole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000462	CcSEcCtD
Pramipexole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00046	CcSEcCtD
Pramipexole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.000459	CcSEcCtD
Pramipexole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000457	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000456	CcSEcCtD
Pramipexole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.000456	CcSEcCtD
Pramipexole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000165	0.000456	CcSEcCtD
Pramipexole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.000454	CcSEcCtD
Pramipexole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000165	0.000454	CcSEcCtD
Pramipexole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000164	0.000453	CcSEcCtD
Pramipexole—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000451	CcSEcCtD
Pramipexole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000451	CcSEcCtD
Pramipexole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00045	CcSEcCtD
Pramipexole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00045	CcSEcCtD
Pramipexole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.000449	CcSEcCtD
Pramipexole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000163	0.000448	CcSEcCtD
Pramipexole—Injury—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000445	CcSEcCtD
Pramipexole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000161	0.000445	CcSEcCtD
Pramipexole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.000444	CcSEcCtD
Pramipexole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000443	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000441	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000441	CcSEcCtD
Pramipexole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000441	CcSEcCtD
Pramipexole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000441	CcSEcCtD
Pramipexole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000441	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00044	CcSEcCtD
Pramipexole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000437	CcSEcCtD
Pramipexole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000437	CcSEcCtD
Pramipexole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000437	CcSEcCtD
Pramipexole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000437	CcSEcCtD
Pramipexole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000436	CcSEcCtD
Pramipexole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000436	CcSEcCtD
Pramipexole—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000436	CcSEcCtD
Pramipexole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000433	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000432	CcSEcCtD
Pramipexole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000432	CcSEcCtD
Pramipexole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00043	CcSEcCtD
Pramipexole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000429	CcSEcCtD
Pramipexole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000428	CcSEcCtD
Pramipexole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000428	CcSEcCtD
Pramipexole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.000427	CcSEcCtD
Pramipexole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000425	CcSEcCtD
Pramipexole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000425	CcSEcCtD
Pramipexole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000425	CcSEcCtD
Pramipexole—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000425	CcSEcCtD
Pramipexole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.000423	CcSEcCtD
Pramipexole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.000423	CcSEcCtD
Pramipexole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000422	CcSEcCtD
Pramipexole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000421	CcSEcCtD
Pramipexole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000421	CcSEcCtD
Pramipexole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.000421	CcSEcCtD
Pramipexole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000419	CcSEcCtD
Pramipexole—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000419	CcSEcCtD
Pramipexole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.000419	CcSEcCtD
Pramipexole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000418	CcSEcCtD
Pramipexole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000418	CcSEcCtD
Pramipexole—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000418	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000417	CcSEcCtD
Pramipexole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000416	CcSEcCtD
Pramipexole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000413	CcSEcCtD
Pramipexole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000413	CcSEcCtD
Pramipexole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000409	CcSEcCtD
Pramipexole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000409	CcSEcCtD
Pramipexole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000409	CcSEcCtD
Pramipexole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000406	CcSEcCtD
Pramipexole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000406	CcSEcCtD
Pramipexole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000404	CcSEcCtD
Pramipexole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000404	CcSEcCtD
Pramipexole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000404	CcSEcCtD
Pramipexole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000404	CcSEcCtD
Pramipexole—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000403	CcSEcCtD
Pramipexole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.000403	CcSEcCtD
Pramipexole—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000145	0.0004	CcSEcCtD
Pramipexole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.000399	CcSEcCtD
Pramipexole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.000399	CcSEcCtD
Pramipexole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.000399	CcSEcCtD
Pramipexole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000398	CcSEcCtD
Pramipexole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000398	CcSEcCtD
Pramipexole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.000397	CcSEcCtD
Pramipexole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000397	CcSEcCtD
Pramipexole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000396	CcSEcCtD
Pramipexole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000396	CcSEcCtD
Pramipexole—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000395	CcSEcCtD
Pramipexole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000395	CcSEcCtD
Pramipexole—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000391	CcSEcCtD
Pramipexole—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000389	CcSEcCtD
Pramipexole—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000388	CcSEcCtD
Pramipexole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000383	CcSEcCtD
Pramipexole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000381	CcSEcCtD
Pramipexole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000381	CcSEcCtD
Pramipexole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000377	CcSEcCtD
Pramipexole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000377	CcSEcCtD
Pramipexole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.000376	CcSEcCtD
Pramipexole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000375	CcSEcCtD
Pramipexole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000375	CcSEcCtD
Pramipexole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000372	CcSEcCtD
Pramipexole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000369	CcSEcCtD
Pramipexole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000367	CcSEcCtD
Pramipexole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000367	CcSEcCtD
Pramipexole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000362	CcSEcCtD
Pramipexole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000362	CcSEcCtD
Pramipexole—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000361	CcSEcCtD
Pramipexole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000359	CcSEcCtD
Pramipexole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000356	CcSEcCtD
Pramipexole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000356	CcSEcCtD
Pramipexole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000354	CcSEcCtD
Pramipexole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00035	CcSEcCtD
Pramipexole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00035	CcSEcCtD
Pramipexole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000347	CcSEcCtD
Pramipexole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000346	CcSEcCtD
Pramipexole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000342	CcSEcCtD
Pramipexole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000341	CcSEcCtD
Pramipexole—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000339	CcSEcCtD
Pramipexole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000338	CcSEcCtD
Pramipexole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000338	CcSEcCtD
Pramipexole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00012	0.000331	CcSEcCtD
Pramipexole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00033	CcSEcCtD
Pramipexole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000326	CcSEcCtD
Pramipexole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000325	CcSEcCtD
Pramipexole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000325	CcSEcCtD
Pramipexole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000322	CcSEcCtD
Pramipexole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000322	CcSEcCtD
Pramipexole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000322	CcSEcCtD
Pramipexole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000322	CcSEcCtD
Pramipexole—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000322	CcSEcCtD
Pramipexole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00032	CcSEcCtD
Pramipexole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00032	CcSEcCtD
Pramipexole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00032	CcSEcCtD
Pramipexole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00032	CcSEcCtD
Pramipexole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000319	CcSEcCtD
Pramipexole—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000319	CcSEcCtD
Pramipexole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000318	CcSEcCtD
Pramipexole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000316	CcSEcCtD
Pramipexole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000315	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000315	CcSEcCtD
Pramipexole—Depression—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000314	CcSEcCtD
Pramipexole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000314	CcSEcCtD
Pramipexole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000311	CcSEcCtD
Pramipexole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000309	CcSEcCtD
Pramipexole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000309	CcSEcCtD
Pramipexole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000307	CcSEcCtD
Pramipexole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000306	CcSEcCtD
Pramipexole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000305	CcSEcCtD
Pramipexole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000304	CcSEcCtD
Pramipexole—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000304	CcSEcCtD
Pramipexole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000304	CcSEcCtD
Pramipexole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000304	CcSEcCtD
Pramipexole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000304	CcSEcCtD
Pramipexole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000302	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000298	CcSEcCtD
Pramipexole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000297	CcSEcCtD
Pramipexole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000294	CcSEcCtD
Pramipexole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000293	CcSEcCtD
Pramipexole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000288	CcSEcCtD
Pramipexole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000287	CcSEcCtD
Pramipexole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000285	CcSEcCtD
Pramipexole—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000282	CcSEcCtD
Pramipexole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000278	CcSEcCtD
Pramipexole—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000277	CcSEcCtD
Pramipexole—Shock—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000272	CcSEcCtD
Pramipexole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.8e-05	0.00027	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.71e-05	0.000268	CcSEcCtD
Pramipexole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000265	CcSEcCtD
Pramipexole—Flushing—Prednisone—chronic obstructive pulmonary disease	9.53e-05	0.000263	CcSEcCtD
Pramipexole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000257	CcSEcCtD
Pramipexole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000256	CcSEcCtD
Pramipexole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.08e-05	0.00025	CcSEcCtD
Pramipexole—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.08e-05	0.00025	CcSEcCtD
Pramipexole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.02e-05	0.000249	CcSEcCtD
Pramipexole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9e-05	0.000248	CcSEcCtD
Pramipexole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000246	CcSEcCtD
Pramipexole—Erythema—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000246	CcSEcCtD
Pramipexole—Pain—Prednisolone—chronic obstructive pulmonary disease	8.59e-05	0.000237	CcSEcCtD
Pramipexole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.000232	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000229	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.000228	CcSEcCtD
Pramipexole—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000228	CcSEcCtD
Pramipexole—Agitation—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000226	CcSEcCtD
Pramipexole—Malaise—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000222	CcSEcCtD
Pramipexole—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000221	CcSEcCtD
Pramipexole—Syncope—Prednisone—chronic obstructive pulmonary disease	8.02e-05	0.000221	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.98e-05	0.00022	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000217	CcSEcCtD
Pramipexole—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000214	CcSEcCtD
Pramipexole—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000213	CcSEcCtD
Pramipexole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.00021	CcSEcCtD
Pramipexole—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.00021	CcSEcCtD
Pramipexole—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000209	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.000208	CcSEcCtD
Pramipexole—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000207	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.4e-05	0.000204	CcSEcCtD
Pramipexole—Oedema—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000201	CcSEcCtD
Pramipexole—Infection—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.0002	CcSEcCtD
Pramipexole—Shock—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000198	CcSEcCtD
Pramipexole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000197	CcSEcCtD
Pramipexole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000196	CcSEcCtD
Pramipexole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000195	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000194	CcSEcCtD
Pramipexole—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.000192	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000183	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.64e-05	0.000183	CcSEcCtD
Pramipexole—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000182	CcSEcCtD
Pramipexole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000181	CcSEcCtD
Pramipexole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000177	CcSEcCtD
Pramipexole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000175	CcSEcCtD
Pramipexole—Rash—Prednisolone—chronic obstructive pulmonary disease	6.33e-05	0.000175	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.33e-05	0.000174	CcSEcCtD
Pramipexole—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.29e-05	0.000173	CcSEcCtD
Pramipexole—Headache—Prednisolone—chronic obstructive pulmonary disease	6.29e-05	0.000173	CcSEcCtD
Pramipexole—Constipation—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.000172	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.000166	CcSEcCtD
Pramipexole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000164	CcSEcCtD
Pramipexole—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.97e-05	0.000164	CcSEcCtD
Pramipexole—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.00016	CcSEcCtD
Pramipexole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000159	CcSEcCtD
Pramipexole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000159	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000148	CcSEcCtD
Pramipexole—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.000144	CcSEcCtD
Pramipexole—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.000142	CcSEcCtD
Pramipexole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000138	CcSEcCtD
Pramipexole—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000133	CcSEcCtD
Pramipexole—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000128	CcSEcCtD
Pramipexole—Rash—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000127	CcSEcCtD
Pramipexole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.6e-05	0.000127	CcSEcCtD
Pramipexole—Headache—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000126	CcSEcCtD
Pramipexole—Nausea—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000119	CcSEcCtD
Pramipexole—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.11e-05	0.000197	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.1e-05	0.000196	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.09e-05	0.000196	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.08e-05	0.000194	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.08e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.08e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.07e-05	0.000194	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.07e-05	0.000193	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.05e-05	0.000191	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.04e-05	0.000191	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.04e-05	0.000191	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.03e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.03e-05	0.000189	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.02e-05	0.000189	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.02e-05	0.000188	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.99e-05	0.000185	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.98e-05	0.000184	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.000183	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.96e-05	0.000183	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.95e-05	0.000182	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.93e-05	0.000181	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.93e-05	0.00018	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.93e-05	0.00018	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.00018	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.91e-05	0.000179	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.9e-05	0.000178	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.9e-05	0.000178	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.9e-05	0.000177	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.89e-05	0.000177	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.89e-05	0.000176	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.88e-05	0.000176	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.88e-05	0.000175	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.86e-05	0.000173	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.84e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.84e-05	0.000172	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	1.84e-05	0.000171	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.000171	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.83e-05	0.00017	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.82e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.82e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.82e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.81e-05	0.000169	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.81e-05	0.000169	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.8e-05	0.000168	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.78e-05	0.000166	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.77e-05	0.000165	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.000164	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.75e-05	0.000164	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.73e-05	0.000161	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.72e-05	0.00016	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	1.72e-05	0.00016	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.00016	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.71e-05	0.00016	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.71e-05	0.000159	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.69e-05	0.000158	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.69e-05	0.000158	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.000157	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.66e-05	0.000155	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.000154	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.65e-05	0.000154	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.64e-05	0.000153	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.64e-05	0.000153	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.63e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.62e-05	0.000152	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.00015	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.00015	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000149	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.59e-05	0.000149	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.59e-05	0.000149	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.59e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.58e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.58e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.58e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.57e-05	0.000146	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.56e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.55e-05	0.000145	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.55e-05	0.000145	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.000143	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.53e-05	0.000142	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.52e-05	0.000142	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.49e-05	0.000139	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.49e-05	0.000139	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.48e-05	0.000138	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.47e-05	0.000138	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.47e-05	0.000137	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000136	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.45e-05	0.000135	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.45e-05	0.000135	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.43e-05	0.000134	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.43e-05	0.000134	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000133	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.43e-05	0.000133	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.43e-05	0.000133	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.42e-05	0.000133	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.42e-05	0.000133	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.41e-05	0.000132	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.39e-05	0.00013	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.39e-05	0.00013	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.00013	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.39e-05	0.00013	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000128	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.36e-05	0.000127	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000126	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000125	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.33e-05	0.000124	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000123	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.3e-05	0.000122	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.29e-05	0.000121	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.29e-05	0.000121	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.29e-05	0.00012	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.00012	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000119	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.28e-05	0.000119	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000119	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.27e-05	0.000119	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000118	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.000118	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000117	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000117	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.25e-05	0.000117	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.25e-05	0.000116	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.22e-05	0.000114	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.22e-05	0.000114	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.21e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.21e-05	0.000113	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.2e-05	0.000112	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.2e-05	0.000112	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.19e-05	0.000111	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000109	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.16e-05	0.000109	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.16e-05	0.000108	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.16e-05	0.000108	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.15e-05	0.000107	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.15e-05	0.000107	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.14e-05	0.000107	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.14e-05	0.000107	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000106	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000105	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.12e-05	0.000104	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.1e-05	0.000103	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.1e-05	0.000103	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.09e-05	0.000102	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000101	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000101	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.07e-05	9.97e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.07e-05	9.97e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.07e-05	9.95e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.06e-05	9.93e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.05e-05	9.82e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.05e-05	9.77e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.04e-05	9.75e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	9.69e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.03e-05	9.61e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.03e-05	9.59e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.02e-05	9.49e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	9.48e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.01e-05	9.47e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.99e-06	9.32e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.81e-06	9.15e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.79e-06	9.14e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.79e-06	9.14e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.74e-06	9.09e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.69e-06	9.05e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.64e-06	9e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.63e-06	8.99e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.59e-06	8.96e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.58e-06	8.94e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.54e-06	8.9e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.52e-06	8.89e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.47e-06	8.84e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.43e-06	8.8e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.39e-06	8.77e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.31e-06	8.69e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.26e-06	8.65e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.25e-06	8.63e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.24e-06	8.63e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.17e-06	8.56e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.12e-06	8.52e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.09e-06	8.48e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.01e-06	8.41e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9e-06	8.4e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.86e-06	8.27e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.83e-06	8.24e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.81e-06	8.23e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.68e-06	8.1e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.6e-06	8.03e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.57e-06	8e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.49e-06	7.92e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.46e-06	7.9e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.37e-06	7.82e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.32e-06	7.77e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.24e-06	7.69e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.21e-06	7.67e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.17e-06	7.63e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.06e-06	7.52e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.04e-06	7.51e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.95e-06	7.42e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.91e-06	7.39e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.89e-06	7.36e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.78e-06	7.26e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.76e-06	7.25e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.7e-06	7.18e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.7e-06	7.18e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.65e-06	7.14e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.56e-06	7.06e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.41e-06	6.92e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.41e-06	6.92e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.37e-06	6.88e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.32e-06	6.83e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.3e-06	6.81e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.26e-06	6.78e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.22e-06	6.74e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.16e-06	6.68e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.12e-06	6.65e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.1e-06	6.63e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.06e-06	6.59e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.99e-06	6.52e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.98e-06	6.52e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.96e-06	6.5e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.92e-06	6.46e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.89e-06	6.44e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.87e-06	6.41e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.78e-06	6.33e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.41e-06	5.98e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.4e-06	5.97e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.31e-06	5.89e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.31e-06	5.89e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.28e-06	5.87e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.25e-06	5.83e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.22e-06	5.81e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.18e-06	5.77e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.01e-06	5.61e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.98e-06	5.58e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.81e-06	5.43e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.74e-06	5.36e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.7e-06	5.32e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.62e-06	5.25e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.5e-06	5.13e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.47e-06	5.11e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.32e-06	4.97e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.28e-06	4.93e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.19e-06	4.85e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.83e-06	4.51e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.75e-06	4.44e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.72e-06	4.41e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.32e-06	4.04e-05	CbGpPWpGaD
